CN1707330A - Optical film and producing method thereof - Google Patents
Optical film and producing method thereof Download PDFInfo
- Publication number
- CN1707330A CN1707330A CN 200410042962 CN200410042962A CN1707330A CN 1707330 A CN1707330 A CN 1707330A CN 200410042962 CN200410042962 CN 200410042962 CN 200410042962 A CN200410042962 A CN 200410042962A CN 1707330 A CN1707330 A CN 1707330A
- Authority
- CN
- China
- Prior art keywords
- liquid crystal
- monomer
- prescription
- cholesterol
- cholesterol liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Liquid Crystal Substances (AREA)
- Liquid Crystal (AREA)
Abstract
The present invention provides one kind of optical film including one transparent substrate and at least one layer of cholesterol type liquid crystal polymer coated to the surface of the substrate. The polymer is formed through polymerizing single functional radical nematic liquid crystal monomer, double functional radical nematic liquid crystal monomer and chiral compound monomer. The optical film of the present invention may be used as Polaroid in LCD and especially brightness increasing film to raise the brightness of LCD.
Description
Technical field
The present invention system is about a kind of blooming, and it comprises a transparent base and one deck cholesterol liquid crystal is polymer-coated in the surface of base material at least, with the polaroid as LCD.Because blooming of the present invention can utilize the multilayer storehouse to adjust its reflection wave frequency range, therefore can effectively promote the brightness of LCD, and be applicable to the LCD of the wide or special frequency range scope of frequency range.
Background technology
Polaroid means the optical material that a selectivity allows the light of specific direction pass through, and is mainly used in to change general non-polarized light into polar biased light.Its mode of action is when as irradiation is one of non-polarized during light source, only allows linear one of them direction of optical axis of pairwise orthogonal to pass through, but another axial light then will absorb by polaroid, in order to control specific light wave polarization direction.
In general liquid crystal display device structure, the polaroid of necessary two quadratures of fitting before and after the liquid crystal panel, because liquid crystal not tool itself makes light by, the control function of covering, and needs reach correlation function with polaroid, could effectively control the bright of each picture element and dark state.The standard polaroid uses the mode of absorption to be filtered light source, the shortcoming of this polaroid is only to have under the optimum condition the highest 50% incident optical energy to be converted into linear polar biased light, therefore cause loss of light source, make the LCD brightness deficiency, also the term of life of remote effect fluorescent tube.Another shortcoming of this type polaroid is that the light source that do not penetrate partly, this partly is absorbed light source will be transformed into a large amount of heat energy for polaroid, and then cause the unpredictable change of polaroid character, especially under the high-energy incident light even may cause the polaroid structural damage.
For addressing the above problem, industry develops a kind of cholesterol type blooming and reclaims the luminous energy that originally must lose.So-called cholesterol liquid crystal is the liquid crystal of a kind of structural similarity in the cholesterol molecule.Cholesterol liquid crystal is formed by the accumulation of nematic (nematics) liquid crystal, in nematic crystal, add chipal compounds (chiral compound), can make the long axis direction of nematic crystal molecule differ an angle rotation gradually and curl, therefore this structure claims that this type of liquid crystal is a cholesterol liquid crystal with the cholesterol molecular mimicry.
Fig. 1 is the synoptic diagram of the LCD of known tradition demonstration (I) and the demonstration (II) with cholesterol type blooming.As shown in Figure 1, be cholesterol liquid crystal blooming (CLC) 14, λ/4 polarizers 16, lower floor's polaroid 18, liquid crystal layer 20 and the upper strata polaroid 22 of reflecting plate 10, light guide plate 12, the left-handed chemical constitution of tool from the bottom to top in regular turn.When light source 24 is lighted, light is through light guide plate 12 diffusions, when light process cholesterol liquid crystal blooming 14, only allow right-handed rotation to pass through this moment, and with left-handed rotation reflected back light source direction, the right-handed rotation of passing through then changes oval polar biased light into by circle polar biased light, therefore needs again by polarizer 16, light is modified to linear polar biased light, and this type light just can be applicable to liquid crystal display system.On the other hand, the left-handed rotation that reflexes to light source direction is converted into right-handed rotation then via after reflecting plate 10 reflections, when it passes through cholesterol liquid crystal blooming 14 again, has changed and can pass through smoothly because of revolving optical activity.Therefore, when the cholesterol liquid crystal blooming existed, light source all was converted into the linear polar biased light of single direction before entering liquid crystal panel, and can not cause a large amount of losses of light source.Therefore claim that this kind cholesterol liquid crystal blooming is the cholesterol type polaroid, expectation can replace the polaroid of tradition.But in fact and be not easy to accomplish, because the light that the cholesterol type polaroid is passed through is behind polarizer, and can't obtain linear polarisation with traditional polaroid same degree, that is its degree of polarization deficiency, this light will cause serious light leakage phenomena after directly entering liquid crystal panel.Therefore, the industry way not only can guarantee the degree of polarization of light source for cholesterol liquid crystal blooming, polarizer and polaroid three are fitted simultaneously at present, also can significantly improve the effective availability of light source.This cholesterol liquid crystal blooming just is referred to as brightness enhancement film at present.
In addition, according to Maxwell's equation (Maxwell) theory: λ=n * p, wherein λ is the wavelength that liquid crystal can reflect, and n is the refractive index of material, and p is a pitch.
Because liquid crystal has the character of birefringence, following formula can be modified to: Δ λ=(n
e-n
o) * p=Δ n * p, wherein Δ λ is the frequency range of reflection wave, n
eBe the liquid crystal material refractive index, and n
oBe general refractive index.
Yet with regard to practicality, the visible light frequency range is about 250nm, but the Δ n value of general liquid crystal is about 0.1～0.2, so its frequency range is about 50～100nm, much smaller than the visible light frequency range, therefore must use the made brightness enhancement film of different liquid crystal materials, do the multilayer storehouse and can use, cause the loaded down with trivial details complexity of this processing procedure.So it is too small how to solve brightness enhancement film effect frequency range, become display industry important topic.
Dreher is at Solid State Communication (Vol.12, pp.519-522,1973), people such as Mazkedian is at J.Physique Colloq. (Vol.36, pp.C1-283,1974) and people such as Hajdo at J.Opt.Soc.Am. (Vol.36, pp.1017,1976) research of being done in points out, can effectively obtain broad reflection wave frequency range at the helicoidal structure of the pitch of depth direction tool Gradient distribution variation.
European patent case EP 0 606 940 A2 once proposed to produce the pitch value of continuous gradient distribution because of diffusional effect with different monomers (chirality and non-chiral compound) polymerization.But if will obtain having the product of wide frequency range, then must additionally add dyestuff cause the intensity of light source with the vertical degree of depth difference of film difference to some extent.The shortcoming of the method is controlled the pitch distribution for do time exposure with low energy light source, and is very harsh for the requirement of thickness.
People such as Pindak is in Phys.Rev.Lett. (Vol.32 in addition, pp.43,1974) once disclosed the pitch variation of controlling cholesterol derivative matter in the mode of control thermograde in, but because the thermal conductive property of macromolecule membrane is good, thermograde in the manufacturing process extremely difficulty is done effective control, becomes the important shortcoming of the method.
This case the inventor find through broad research, and the blooming that the cholesterol liquid crystal polymkeric substance is made utilizes the monomer mixing proportion difference of its prescription, can get different reflection waves.Utilize the multilayer storehouse to make its reflection wave frequency range can contain the visible light frequency range, can effectively solve the aforesaid drawbacks.
Summary of the invention
The present invention's purpose system provides a kind of blooming, and it comprises the transparent base of macromolecule resin and one deck cholesterol liquid crystal is polymer-coated in the surface of this base material at least.This blooming can be used in the LCD as polaroid, and brightness enhancement film particularly is to improve the brightness of LCD.
Another object of the present invention is to provide a kind of cholesterol liquid crystal prescription, can be in order to form blooming.
The present invention's another purpose is to provide a kind of method of manufacturing blooming.
The accompanying drawing simple declaration
Fig. 1 is the synoptic diagram of the LCD of known tradition demonstration (I) and the demonstration (II) with cholesterol type blooming.
Fig. 2 is the spectrum of the reflected waveband frequency range of the prescription of the cholesterol liquid crystal among the present invention's the embodiment 1 to 31 to 3.
Fig. 3 is the spectrum of the reflected waveband frequency range of the prescription of the cholesterol liquid crystal among the present invention's the embodiment 4 to 91 to 3.
The simple declaration of accompanying drawing element numbers
10 reflecting plates
12 light guide plate
14 cholesterol liquid crystal bloomings
16 λ/4 polarizers
18 lower floor's polaroids
20 liquid crystal layers
22 upper strata polaroids
24 light sources
Embodiment
The macromolecule resin that blooming of the present invention used there is no particular restriction, it can be vibrin (polyester resin), polycarbonate resin (polycarbonate resin) or polyurethane resin (polyurethane resin) or its potpourri, is preferably polyethylene terephthalate (PET).
The present invention's cholesterol liquid crystal polymkeric substance is polymerized by a cholesterol liquid crystal prescription, and this prescription comprises:
(1) monofunctional nematic crystal monomer;
(2) difunctionality base nematic liquid crystal monomer;
(3) chipal compounds monomer; And
(4) light initiator.
The monofunctional nematic crystal monomer and the difunctionality base nematic liquid crystal monomer that can be used for forming polymkeric substance among the present invention can be selected from the group that is made up of the following structural formula of tool respectively:
(1) monofunctional nematic crystal monomer
(2) difunctionality base nematic liquid crystal monomer
Wherein, R is C
1-C
10Stretch alkyl or C
1-C
10Stretch alkoxy, X is for being selected from cyano group, C
1-C
10Alkoxy and C
1-C
10One terminal groups of alkyl, and Ar is by being selected from the group that is made up of group's base of following tool liquid crystal phase:
And
Wherein, A is for being selected from by from hydrogen atom, C
1-C
6Another terminal groups of the group that alkyl and halogen atom are formed.
Can be used for forming the chipal compounds monomer of polymkeric substance among the present invention, is monofunctional chipal compounds monomer, the group that the following structural formula of optional free tool is formed:
Wherein, R is C
1-C
10Stretch alkyl or C
1-C
10Stretch alkoxy, X is for being selected from by cyano group, C
1-C
10Alkoxy and C
1-C
10One of the group that alkyl is formed terminal groups, and Ar is the basic group that is formed of the group that is selected from following tool liquid crystal phase:
Wherein, A is for being selected from by hydrogen atom, C
1-C
6Another terminal groups of the group that alkyl and halogen atom are formed; Wherein Y for be selected from by cholesterol,
And
The optical activity group base that can form liquid crystal phase.
In the present invention, halogen atom can be fluorine, chlorine, bromine or iodine atom.
In addition, in the present invention's preferable enforcement aspect, monofunctional nematic crystal monomer can be the following structural formula person of tool:
In the present invention's preferable enforcement aspect, difunctionality base nematic liquid crystal monomer can be and is selected from following structural person:
Formula (B)
Formula (C)
In the present invention's preferable enforcement aspect, monofunctional chipal compounds monomer can be and is selected from following structural person:
Formula (D)
In the present invention's cholesterol liquid crystal prescription, monofunctional nematic crystal single mass system accounts for about 30 to 60 percentage by weights (wt%) of cholesterol liquid crystal prescription, is preferably about 40 to 50wt%; Difunctionality base nematic liquid crystal monomer system account for the cholesterol liquid crystal prescription about 30 to 60wt%, be preferably about 40 to 50wt%; And the chipal compounds single mass system accounts for the about 1 to 20wt% of cholesterol liquid crystal prescription, is preferably about 5 to 15wt%.
The present invention can be used for forming the light initiator of polymkeric substance, is the personage institute well known of haveing the knack of this technology, such as but not limited to 2,4,6-trimethylbenzene formyl diphenyl phosphine oxide (2,4,6-trimethyl benzoyl diphenyl phosphine oxide, TPO).In the present invention's cholesterol liquid crystal prescription, light initiator system account for the cholesterol liquid crystal prescription about 0.1 to 10wt%, be preferably about 1 to 5wt%.
The present invention's cholesterol liquid crystal prescription can optionally add various adjuvants, as smooth dose, and such as but not limited to acrylate copolymer, BYK-361.In the present invention's cholesterol liquid crystal prescription, the consumption system of adjuvant account for the cholesterol liquid crystal prescription about 0.05 to 5wt%, be preferably about 0.1 to 2wt%.
By the obtained polymkeric substance of cholesterol liquid crystal of the present invention prescription, can be used in the LCD as the material of blooming, this blooming can be used as the purposes of brightness enhancement film.
In addition, the present invention provides a kind of method of preparation blooming in addition, and it comprises following steps:
(a) with nematic crystal monomer and the blending of chipal compounds monomer, add the light inlet initiator then, to form a cholesterol liquid crystal prescription;
(b) the cholesterol liquid crystal prescription is coated on the transparent base;
(c) under normal temperature or heating, cholesterol liquid crystal is filled a prescription the irradiation energy ray to carry out photopolymerization reaction.
In preparation method of the present invention, the cholesterol liquid crystal prescription is carried out the employed energy-ray of photopolymerization, the light source of general reference certain limit wavelength, for example ultraviolet light, infrared light, visible light or hot line (radiation or radiation) etc., be preferably ultraviolet light, irradiation intensity is about 0.1 to 10 watt of/square centimeter (W/cm
2), be preferably 1 to 5W/cm
2
In preparation method of the present invention, the temperature of application step or polymerization procedure is controlled at about 20 to 40 ℃, is preferably about 30 ℃.
The thickness of coating the cholesterol liquid crystal prescription on the transparent base is about 2 to 25 microns, is preferably about 3 to 10 microns.Can optionally repeat said method on transparent base, to repeat to increase layer, make prepared blooming have in a big way visible light frequency range.
Following examples will be done further explanation to the present invention, but be not the practical range in order to restriction the present invention, anyly be familiar with the technology of the present invention field person, without prejudice to the present invention's spirit following modification of being reached and variation, all belong to the present invention's scope.
Embodiment
Each monomer structure that is used in the embodiment of the invention is as follows:
Monofunctional nematic crystal monomer (a)
Difunctionality base nematic liquid crystal monomer (b)
Difunctionality base nematic liquid crystal monomer (c)
Monofunctional chiral monomer (d)
Embodiment 1-3
Get the above-mentioned monomer (a) and (b) of different proportion with (d), smooth dose and light initiator to be forming cholesterol liquid crystal prescription 1,2 and 3, and be as shown in table 1:
Table 1
| Dispensing liquid crystal | ??1 | ??2 | ??3 | |||
| Monofunctional nematic crystal monomer (a) | ??46％ | ??98wt％ | ??45％ | ??98wt％ | ??44％ | ??98wt％ |
| Difunctionality base nematic liquid crystal monomer (b) | ??46％ | ??45％ | ??44％ | |||
| Monofunctional chiral monomer (d) | ??8％ | ??10％ | ??12％ | |||
| Smooth dose (BYK-361) | ????1wt％ | ?????1wt％ | ??????1wt％ | |||
| Light initiator (TPO) | ????1wt％ | ?????1wt％ | ??????1wt％ | |||
Determine the photochromic essential condition of resultant prescription reflection to be the mixing proportion of chiral monomer, but the ruddiness zone of the less person's reflects shorter-wavelength of contained ratio, otherwise then can get blue light, but exceed the compositing formula then extra-regional infrared light of reflect visible light or the ultraviolet light that are suitable for content range, do not have actual value.
Dispensing liquid crystal 1,2 and 3 is formed blooming with the present invention's method for making respectively, with as monochromatic brightness enhancement film.Fig. 2 represents with I, II and III respectively for the spectrum of the reflected waveband frequency range of the prescription of the cholesterol liquid crystal among the present invention's the embodiment 1 to 31 to 3.Wherein, prescription 1 is the red spectral band brightness enhancement film, and effective wavelength range is about 576 to 694 millimicrons (nm), prescription 2 is the green light band brightness enhancement film, effective wavelength range is about 492 to 586nm, and prescription 3 is the blue wave band brightness enhancement film, and effective wavelength range is about 400 to 492nm.
By above-mentioned data presentation, the stack product of three layers of brightness enhancement film that use the present invention's cholesterol liquid crystal prescription is obtained, (effective wavelength range is about 426～686nm) can effectively to have contained whole visible light frequency range.
Embodiment 4-9
Get the above-mentioned monomer (a), (c) of different proportion with (d), smooth dose and light initiator to be forming cholesterol liquid crystal prescription 4 to 9, and be as shown in table 2:
Table 2
| Dispensing liquid crystal | ??4 | ??5 | ??6 | |||
| Monofunctional nematic crystal monomer (a) | ??47.5％ | ??98wt％ | ??47％ | ??98wt％ | ??46.5％ | ??98wt％ |
| Difunctionality base nematic liquid crystal monomer (c) | ??47.5％ | ??47％ | ??46.5％ | |||
| Monofunctional chiral monomer (d) | ??5％ | ??6％ | ??7％ | |||
| Smooth dose (BYK-361) | ?????1wt％ | ?????1wt％ | ?????1wt％ | |||
| Light initiator (TPO) | ?????1wt％ | ?????1wt％ | ?????1wt％ | |||
| Dispensing liquid crystal | ??7 | ??8 | ??9 | |||
| Monofunctional nematic crystal monomer (a) | ??46％ | ??98wt％ | ??45.5％ | ??98wt％ | ??45％ | ??98wt％ |
| Difunctionality base nematic liquid crystal monomer (c) | ??46％ | ??45.5％ | ??45％ | |||
| Monofunctional chiral monomer (d) | ??8％ | ??9％ | ??10％ | |||
| Smooth dose (BYK-361) | ?????1wt％ | ?????1wt％ | ?????1wt％ | |||
| Light initiator (TPO) | ?????1wt％ | ?????1wt％ | ?????1wt％ | |||
Prescription 4 to 9 is to use the difunctionality base nematic liquid crystal monomer different with the prescription 1 to 3 of embodiment 1 to 3, and mainly difference is that monomer (b) is a tool high birefringence rate value material, and monomer (c) then is a tool low birefringence value material.By aforementioned Maxwell's equation theory as can be known the birefringence value of material can directly influence the frequency range of reflected waveband, therefore, institute's preparation formula all has narrower reflected waveband frequency range in embodiment 4 to 9, as shown in Figure 3, Fig. 3 is the spectrum of the reflected waveband frequency range of the prescription of the cholesterol liquid crystal among the present invention's the embodiment 4 to 94 to 9.
Therefore, if promptly must show with the stack of more bloomings with 4 to the 9 making total visible light wave band brightness enhancement film of filling a prescription.Say it for example, can select the brightness enhancement film of embodiment 6 to 9, utilize four stacked Calais to obtain the visible spectrum brightness enhancement film.
In sum, the present invention's cholesterol liquid crystal prescription can utilize the processing procedure of simple and easy control, make brightness enhancement film in forming by prescription flexibly with suitable reflected waveband, not only can effectively promote the brightness of LCD, and can utilize the multilayer storehouse effectively to contain whole visible light frequency range, being applied to need display as one of full spectrum white-light, or be applied to the special displays drive pattern of special frequency range scope.
Claim system is in order to define the present invention's Reasonable Protection scope.So should the person of understanding, all apparent improvement that skill personage can reach based on the present invention's announcement also should belong to the reasonable protection domain of the present invention.
Claims (20)
1. blooming comprises a transparent base and one deck cholesterol liquid crystal is polymer-coated in the surface of this base material at least, it is characterized in that this polymer system is formed by following monomer polymerization:
(a) monofunctional nematic crystal monomer;
(b) difunctionality base nematic liquid crystal monomer; And
(c) chipal compounds monomer.
2. blooming as claimed in claim 1, it is as brightness enhancement film.
3. blooming as claimed in claim 1, wherein this base material comprises macromolecule resin.
4. blooming as claimed in claim 3, wherein this macromolecule resin is selected from vibrin, polycarbonate resin and polyurethane resin.
5. blooming as claimed in claim 3, wherein this macromolecule resin is a polyethylene terephthalate.
6. cholesterol liquid crystal prescription comprises:
(a) monofunctional nematic crystal monomer;
(b) difunctionality base nematic liquid crystal monomer;
(c) chipal compounds monomer; And
(d) light initiator.
7. cholesterol liquid crystal prescription as claimed in claim 6, wherein this monofunctional nematic crystal monomer is selected from and has the group that following structural formula is formed:
Wherein, R is C
1-C
10Stretch alkyl or C
1-C
10Stretch alkoxy, X is for being selected from cyano group, C
1-C
10Alkoxy and C
1-C
10One terminal groups of alkyl, and Ar is for being selected from following tool liquid crystal phase group:
And
Wherein, A is for being selected from hydrogen atom, C
1-C
6Another terminal groups of alkyl and halogen atom.
8. cholesterol liquid crystal prescription as claimed in claim 7, wherein this monofunctional nematic crystal monomer cording formula (A) structure:
Formula (A).
9. cholesterol liquid crystal prescription as claimed in claim 6, wherein this difunctionality base nematic liquid crystal monomer system is selected from the group that is made up of the following structural formula of tool:
Wherein, R is C
1-C
10Stretch alkyl or C
1-C
10Stretch alkoxy, and Ar is for being selected from the group of following tool liquid crystal phase:
Wherein, A is for being selected from hydrogen atom, C
1-C
6Another terminal groups of alkyl and halogen atom.
10. cholesterol liquid crystal prescription as claimed in claim 9, wherein this difunctionality base nematic liquid crystal monomer system is selected from formula (B) or formula (C) structure:
Formula (B)
11. cholesterol liquid crystal prescription as claimed in claim 6, wherein this chipal compounds monomer is a monofunctional chipal compounds monomer.
12. cholesterol liquid crystal prescription as claimed in claim 11, wherein this chipal compounds single mass system is selected from the group that is made up of the following structural formula of tool:
And
Wherein, R is C
1-C
10Stretch alkyl or C
1-C
10Stretch alkoxy, and Ar is for being selected from the group of following tool liquid crystal phase:
Wherein, A is for being selected from hydrogen atom, C
1-C
6Another terminal groups of alkyl and halogen atom; Wherein Y for be selected from cholesterol,
Can form liquid crystal phase revolve optical activity group base.
13. cholesterol liquid crystal prescription as claimed in claim 12, wherein this chipal compounds monomer cording formula (D) structure:
Formula (D).
14. cholesterol liquid crystal prescription as claimed in claim 6, it further comprises smooth dose.
15. a method for preparing blooming, it comprises following steps:
(a) with nematic crystal monomer and the blending of chipal compounds monomer, add the light inlet initiator then, to form a cholesterol liquid crystal prescription;
(b) this cholesterol liquid crystal prescription is coated on the transparent base; And
(c) under normal temperature or heating, this cholesterol liquid crystal is filled a prescription irradiation energy ray to carry out photopolymerization reaction.
16. method as claimed in claim 15, wherein this energy-ray is a ultraviolet light.
17. method as claimed in claim 15, wherein the photopolymerization reaction temperature is about 20 to 40 ℃.
18. method as claimed in claim 17, wherein the photopolymerization reaction temperature is about 30 ℃.
19. method as claimed in claim 15, wherein to coat the thickness on this transparent base be 2 to 25 microns to this cholesterol liquid crystal prescription.
20. method as claimed in claim 15, wherein these steps can repeat for several times.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200410042962XA CN100485481C (en) | 2004-06-04 | 2004-06-04 | Optical film and producing method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200410042962XA CN100485481C (en) | 2004-06-04 | 2004-06-04 | Optical film and producing method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1707330A true CN1707330A (en) | 2005-12-14 |
| CN100485481C CN100485481C (en) | 2009-05-06 |
Family
ID=35581324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200410042962XA Expired - Fee Related CN100485481C (en) | 2004-06-04 | 2004-06-04 | Optical film and producing method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100485481C (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103074074A (en) * | 2011-10-26 | 2013-05-01 | 东莞万士达液晶显示器有限公司 | Light-modulatable composition and formation method |
| CN103448343A (en) * | 2013-09-09 | 2013-12-18 | 南京凯尚信息科技有限公司 | Full-spectrum liquid crystal brightness enhancement film preparation technology |
| US8908130B2 (en) | 2008-11-06 | 2014-12-09 | Industrial Technology Research Institute | Optical elements, backlight modules, and liquid crystal display employing the same |
| JP2017111394A (en) * | 2015-12-18 | 2017-06-22 | 日本ゼオン株式会社 | Manufacturing method for optical films |
| US10253259B2 (en) | 2013-04-17 | 2019-04-09 | Jnc Corporation | Polymerizable compound having conjugated bonds, liquid crystal composition and liquid crystal display device |
| CN114280860A (en) * | 2022-02-23 | 2022-04-05 | 四川龙华光电薄膜股份有限公司 | Liquid crystal film and preparation method and application thereof |
-
2004
- 2004-06-04 CN CNB200410042962XA patent/CN100485481C/en not_active Expired - Fee Related
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8908130B2 (en) | 2008-11-06 | 2014-12-09 | Industrial Technology Research Institute | Optical elements, backlight modules, and liquid crystal display employing the same |
| CN103074074A (en) * | 2011-10-26 | 2013-05-01 | 东莞万士达液晶显示器有限公司 | Light-modulatable composition and formation method |
| US10253259B2 (en) | 2013-04-17 | 2019-04-09 | Jnc Corporation | Polymerizable compound having conjugated bonds, liquid crystal composition and liquid crystal display device |
| CN103448343A (en) * | 2013-09-09 | 2013-12-18 | 南京凯尚信息科技有限公司 | Full-spectrum liquid crystal brightness enhancement film preparation technology |
| CN103448343B (en) * | 2013-09-09 | 2017-09-19 | 江苏中兴博盈商贸集团有限公司 | A kind of full spectrum liquid crystal brightness enhancement film manufacturing technology |
| JP2017111394A (en) * | 2015-12-18 | 2017-06-22 | 日本ゼオン株式会社 | Manufacturing method for optical films |
| CN114280860A (en) * | 2022-02-23 | 2022-04-05 | 四川龙华光电薄膜股份有限公司 | Liquid crystal film and preparation method and application thereof |
| CN114280860B (en) * | 2022-02-23 | 2024-03-29 | 四川龙华光电薄膜股份有限公司 | Liquid crystal film and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100485481C (en) | 2009-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1285954C (en) | Optical bodies containing cholesteric liquid crystal material and methods of manufacture | |
| CN1170193C (en) | Optical component, orientation layer, and layerable polymerisable mixture | |
| CN1083579C (en) | Optical part | |
| CN1106586C (en) | Super broad-band polarizing relfective material | |
| CN103733127B (en) | Liquid crystal indicator | |
| CN1253734C (en) | Cholesteric liquid crystal optical bodies and methods of manufacture | |
| JP4801056B2 (en) | Method for producing multilayer cholesteric liquid crystal optical body | |
| TWI466775B (en) | Liquid crystal film | |
| CN101354459B (en) | Method for preparing liquid-crystal film material capable of reflecting circle polarized light and non-polarized light | |
| JP6530763B2 (en) | Image display function mirror | |
| CN109154770A (en) | Transparent membrane, transparent screen and image display system and transparent poster | |
| TWI359986B (en) | Cholesteric liquid crystal optical bodies and meth | |
| CN106200186A (en) | A kind of liquid crystal handwriting device and preparation method thereof | |
| CN104378970B (en) | Cultivation method for asteridae plants | |
| CN1934222A (en) | Liquid crystal materials | |
| CN1854827A (en) | Display device | |
| CN101710192B (en) | Preparation method of liquid crystal polarizing film with characteristic of ultra-wide wave reflection | |
| CN1798991A (en) | Polymer film with a helical molecular structure | |
| JP2008129483A (en) | Color purity enhancement sheet, optical device, image display device, liquid crystal display and solar cell | |
| CN105062504B (en) | A kind of brightness enhancement film polymerizability liquid-crystal composition | |
| CN1302089C (en) | Polymerisable mixtures | |
| CN1707330A (en) | Optical film and producing method thereof | |
| CN109143711B (en) | Transparent blue-light-proof protective film and preparation method thereof | |
| EP2351809A1 (en) | An anti-counterfeit film with an amphichroic pattern and a preparation method thereof | |
| CN113777841A (en) | Reflector as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP01 | Change in the name or title of a patent holder |
Address after: Kaohsiung City, Taiwan, China Patentee after: Changxing material industry limited-liability company Address before: Kaohsiung City, Taiwan, China Patentee before: Changxing Chemical Industrial Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090506 Termination date: 20170604 |